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Chronic exposure to ultraviolet radiation suppresses
T cell-mediated immune responses and induces the
formation of suppressor T lymphocytes that prevent
the rejection of highly antigenic ultraviolet-induced
skin cancers in mice. Tamarind seed xyloglucans and
pectinic oligogalacturonides prevent suppression of
delayed-type hypersensitivity immune responses in
mice to Candida albicans and alloantigen caused by a
single exposure of ultraviolet radiation. We therefore
investigated the ability of these poly/oligosaccharides
to prevent suppression of T cell-mediated immune
responses and suppressor cell induction during
chronic ultraviolet irradiation and to preserve the
capacity of ultraviolet-irradiated mice to reject a
transplanted, highly antigenic, ultraviolet-induced
tumor. C3H/HeN mice were treated 33 per week
for 12wk with 15 kJ per m2 ultraviolet B radiation
followed by application of the polysaccharides/
oligosaccharides. The delayed-type hypersensitivity
responses to C. albicans and alloantigen were
measured after 1, 6, and 12wk of treatment.
Following the 12th wk of treatment the remaining
mice were injected with the highly antigenic
ultraviolet-induced, syngeneic tumor cell line
UV5497-5. The polysaccharides/oligosaccharides
protected delayed-type hypersensitivity responses to
C. albicans but not contact hypersensitivity responses
to dinitro¯uorobenzene for up to 6 wk of ultraviolet
radiation after which protection declined and sup-
pressor cells were observed. In contrast, the delayed-
type hypersensitivity response to alloantigen was
preserved for the entire 12wk of ultraviolet irradi-
ation. Despite protection of immunity to alloantigen,
the transplanted tumor cells grew equally well in all
ultraviolet-irradiated animals. These results indicate
that delayed-type hypersensitivity responses are
heterogeneous and that delayed-type hypersensitivity
to alloantigen is not a surrogate marker for rejection
of ultraviolet-induced skin tumors. Key words: allo-
antigen/Candida albicans/chronic ultraviolet B/contact
hypersensitivity/delayed-type hypersensitivity/oligosacchar-
ides/polysaccharides/suppression/tolerance. J Invest Dermatol
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xcessive exposure to ultraviolet (UV) radiation is
harmful, causing sunburn, premature aging of the skin,
and mutations leading to skin cancer (Urbach, 1989;
Ullrich, 1995). Studies in laboratory animals have
shown that UV radiation in the ``B'' range (280±
320 nm) of the electromagnetic spectrum also contributes to the
growth of highly antigenic skin cancers by suppressing T cell-
mediated immune responses and inducing the formation of tumor-
speci®c suppressor T cells (Kripke, 1974; Fisher and Kripke, 1977).
Suppression of immune responses to skin tumors occurs at lower
doses of UV radiation than are required to cause malignant
transformation (Kripke, 1974; De Fabo and Kripke, 1979; Sontag
et al, 1997). Complete suppression of tumor immunity requires the
repeated delivery of a subcarcinogenic dose of UV radiation over a
period of several weeks.
Model systems designed to clarify the role of the immune
response in tumor rejection show that UV radiation suppresses a
variety of T cell-mediated immune responses to haptens and
protein antigens. Cutaneous exposure of mice to low (suberythe-
mal) doses of UV radiation locally inhibits the induction of contact
hypersensitivity (CHS) response to hapten applied through the
irradiated skin but not to antigen applied at a distant unirradiated
site (Toews et al, 1980). A single exposure to higher doses of UVB
radiation induces systemic suppression of CHS responses to hapten
applied to unirradiated sites and of delayed-type hypersensitivity
(DTH) responses to both alloantigen and infectious agents,
including herpes simplex virus, leishmania, Candida albicans, and
mycobacteria (Giannini, 1986; Otani and Mori, 1987; Denkins et al,
1989; Jeevan and Kripke, 1989). Yoshikawa et al (1990) suggest that
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this suppression is relevant to humans as susceptibility to UV-
induced immune suppression of CHS responses is a risk factor for
the development of human skin cancer.
Results obtained using model antigens and a single exposure to
much lower amounts of UV radiation than are required to induce
tumors or suppress tumor immunity are frequently equated to
mechanisms involved in tumor rejection with little evidence of
their parity. There are several reasons why it is important to
con®rm these results using chronic UV irradiation. First, the
amounts of UV radiation required to cause malignant transforma-
tion and to suppress tumor-speci®c immune responses are different.
UV carcinogenesis requires high doses of UV radiation given over a
long period of time and re¯ects both the accumulation of genetic
mutations and factors, such as immune suppression that contribute
to progression of the neotransformed cells (Daynes et al, 1986;
Sontag et al, 1997). Second, although partial suppression of T cell-
mediated responses to UV-induced tumors can be accomplished by
a single, very high dose of UVB radiation, complete, long-lived
suppression of tumor immunity requires at least 5 wk of UV
exposure at a cumulative dose of 150 kJ per m2 UVB radiation
(Kripke, 1974). Third, a single exposure to UV radiation is less
effective at suppressing tumor rejection responses than the same
amount of radiation is fractionated and given as multiple smaller
doses, suggesting that the biologic responses to these two treatment
regimens differ (De Fabo and Kripke, 1979). Finally, Steerenberg
et al (1998) failed to ®nd a correlation between CHS responses to
hapten and UV carcinogenesis in SKH-1 mice. Their results
showed that the plant ¯avonoid quercetin, completely protected
CHS responses to picryl chloride from suppression by chronic
exposure to UV radiation but did not affect the onset or growth of
UVB-induced nonmelanoma skin tumors. Thus, data obtained
using model antigens or a single exposure to much lower amounts
of UV radiation than are required to induce tumors or suppress
tumor immunity may not re¯ect mechanisms involved in tumor
rejection.
Currently, the role of DTH responses in the rejection of
nonmelanoma tumors induced by chronic UV irradiation is unclear
both in humans and laboratory animals. We have used biologically
active plant polysaccharides and oligosaccharides as pharmacologic
probes of mechanisms of immune suppression by UV radiation
(Byeon et al, 1998; Strickland et al, 1999). The results of those
studies showed that both tamarind seed xyloglucan (XG)
polysaccharides and pectinic oligalacturonide (OGA) oligosacchar-
ides were effective at preventing suppression of DTH immune
responses from a single exposure with up to 30 kJ per m2 UVB
radiation (Strickland et al, 1999). Our study assesses protection of
CHS to dinitro¯uorobenzene (DNFB) and DTH responses in C3H
mice to C. albicans and alloantigen afforded by the polysaccharides/
oligosaccharides to chronic exposure to UV radiation. We further
investigate the relationship between immune responses to these
model antigens and the ability of the mice to reject a UV-induced,
syngeneic ®brosarcoma.
MATERIALS AND METHODS
Mice Speci®c-pathogen-free (murine tumor virus-negative, MTV±)
female C3H/HeN mice were purchased from the Animal Production
Area of the Frederick Cancer Research Facility (Frederick, MD). Female
BALB/C mice were purchased from Harlan Sprague Dawley (Houston,
TX). All animals were maintained in a pathogen-free barrier facility in
accordance with National Institutes of Health and American Association for
Assessment and Accreditation of Laboratory Animal Care International
guidelines. The mice were housed in ®lter-protected cages and provided
with National Institutes of Health open formula mouse chow and sterile
water ad libitum. All procedures were approved by the Institutional Animal
Care and Use Committee. Each experiment was performed with age-
matched mice 10±12 wk old.
Tumor cell line The UV5497-5 cell line was recently derived from a
UV-induced ®brosarcoma from a C3H/HeN mouse and was a kind gift
from Dr. Margaret Kripke, Department of Immunology, MD Anderson
Cancer Center. The cells were grown in antibiotic-free minimal essential
medium supplemented with 10% fetal bovine serum, 200 mM L-glutamine,
vitamins, and nonessential amino acids (Gibco, Grand Island, NY), and
maintained in our laboratory.
UV radiation UV radiation was administered in vivo using a bank of six
un®ltered FS40 sunlamps (National Biological, Twinsburg, OH).
Approximately 65% of the energy emitted from these lamps is within the
UVB range (280±320 nm) and the peak emission is at 313 nm. The average
irradiance of the source was approximately 7.1 W per m2 at 20 cm distance,
as measured by an IL1700 radiometer with an SEE280 ®lter and a Watt
quartz diffuser (International Light, Newburyport, MA).
Preparation of polysaccharides/oligosaccharides Ten grams of
tamarind seed powder (C.E. Roeper GmbH, Hamburg, Germany) was
suspended in 2 liters of water, stirred overnight at 4°C and centrifuged for
30 min at 10,000 rpm using a JA-10 rotor and Beckman J2-HS centrifuge
(Beckman Instruments, Palo Alto, CA). The supernatant was collected and
adjusted with 100% ethanol to a ®nal concentration of 70% and chilled
overnight at 4°C. The precipitate containing the XG was collected by
centrifugation for 30 min at 10,000 rpm. The pellet was dissolved in water
and lyophilized.
Polygalacturonic acid (Sigma, St Louis, MO) was dissolved in 20 mM
sodium acetate pH 5.0 to make a 2% solution and 5 ppm bovine serum
albumin was added. The solution was treated for 8 h at ambient
temperature with a-(1-4)-endopolygalacturonase puri®ed from Fusarium
moniliforme. The enzymatic reaction was stopped by autoclaving the
solution for 15 min. To precipitate the OGA, the solution was adjusted to
50 mM sodium acetate by addition of sodium acetate crystals and with
100% ethanol to a ®nal concentration of 11%. The mixture was kept at 4°C
overnight. The precipitate was collected by centrifugation for 30 min at
12,500 rpm at 4°C, redissolved in water, dialyzed (2000 mW cutoff
SpectraPor7 tubing, Spectrum Medical Industries, Los Angeles, CA), and
lyophilized. These polysaccharides/oligosaccharides do not absorb UV light
at wavelengths above 220 nm.
Treatment of mice Tamarind and OGA polysaccharides/
oligosaccharides were dissolved in phosphate-buffered saline (PBS) in
1 mg per ml and 100 mg per ml concentrated stock solutions and stored at
±20°C. Each week a fresh working stock solution was prepared and stored
at 4°C. The dorsal fur of mice was shaved with electric clippers at least once
weekly. The animals were put into cages covered with a wire lid. The
incident light received by the animals under these conditions was reduced
to 2.6 W per m2, by shielding from the wire cage top. The animals were
exposed to 15 kJ per m2 UVB radiation 33 per wk for 12 wk. Within 1 h
after each UV irradiation, the UV-exposed skin was treated with 1 mg each
of tamarind XG polysaccharide or OGA in PBS. As some polysaccharides/
oligosaccharides adhere tightly to cellulose, the materials were manually
applied using latex gloves. Control animals were treated in an identical
manner but were not exposed to UV radiation. At 1 wk, 6 wk, and 12 wk
after the start of the experiment and 2 h after the last treatment, groups of
®ve mice were injected subcutaneously in each ¯ank with 13107 formalin-
®xed C. albicans cells. Other mice were injected with 53107 each BALB/C
spleen cells. Ten days after sensitization, the mice were challenged with
50 ml of commercially prepared soluble Candida antigen, supplied as a
1 : 100 dilution (Allercheck Laboratories, Portland, ME) in each hind
footpad. Animals sensitized with alloantigen were challenged in each hind
footpad with 50 ml containing 13107 BALB/C spleen cells in serum-free
RPMI medium. Footpad thickness (dorsal to plantar aspect) was measured
immediately before challenge and 24 h later using an engineer's micrometer
(Production Tools, Houston, TX). Control mice were not sensitized but
were challenged in both hind footpads with soluble Candida antigen or
alloantigen. Speci®c footpad swelling was determined by subtracting the
average values obtained from mice challenged but not sensitized. After
12 wk, the remaining mice were injected with a single cell suspension of
53105 syngeneic UV5497-5 tumor cells subcutaneously in the right ¯ank
of each mouse. A group of 10 untreated C3H/HeN mice were exposed to
450 R X-irradiation 24 h before receiving tumor cells. All mice were
inspected weekly for tumor growth.
Suppressor cell assay To determine whether UV radiation-induced
suppressor cell formation, the UV-irradiated mice were killed immediately
after measurement of their DTH response and their spleens were removed.
A single-cell suspension was made, and their splenocytes were washed
twice in serum-free RPMI 1640 Medium (Gibco, Grand island, NY). The
splenocytes were injected intravenously into naõÈve C3H mice, 13108
nucleated cells per animal. A control group received spleen cells from
untreated syngeneic animals. The spleen cell recipients were then sensitized
with C. albicans or 53107 BALB/C spleen cells (alloantigen) and challenged
10 d later as described above.
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Contact sensitization Groups of ®ve C3H/HeN mice were
anesthetized with Nembutal (sodium pentobarbital, 0.01 ml per g body
weight; MD Anderson Pharmacy, manufactured by Abbott Laboratories,
Northbrook, IL) intraperitoneally and their shaved ventral skin was
exposed to a single dose of 2 kJ per m2 UVB radiation. Control mice were
treated in an identical manner but were not exposed to UV radiation. UV-
irradiated and control mice were sensitized on their shaved abdominal skin
by applying 50 ml of 0.3% DNFB in acetone solution 3 d after UV
irradiation. Six days after sensitization, the mice were challenged by
painting 5 ml of 0.2% DNFB in acetone on the ventral and dorsal surfaces of
each ear. Ear thickness was measured using an engineer's micrometer
immediately before challenge and 24 h later. Speci®c ear swelling was
determined by subtracting the values obtained from the mice that were
challenged but not sensitized.
Statistics Statistical analyses were performed using ANOVA or two-tailed
Student's t test. P < 0.05 was considered signi®cant. Analyses were
performed using Statview 4.5 software (Abacus Concepts, Berkeley, CA)
on a Power Macintosh 8600 microcomputer.
RESULTS
Protection of DTH immunity from suppression by acute,
repeated exposure to UV radiation We have previously
demonstrated that tamarind XG and OGA prevent suppression of
DTH immunity to C. albicans and alloantigen by a single exposure
to UV radiation (Strickland et al, 1999). Therefore, we investigated
the ability of the therapeutic saccharides to protect DTH immune
responses from repeated exposure to UV radiation. The shaved
dorsal skin of C3H/HeN mice was treated with 15 kJ per m2 of
UVB three times for 1 wk. A solution of tamarind XG
polysaccharides or OGA oligosaccharides in PBS was applied to
the irradiated skin of the animals within 1 h after each exposure to
UV radiation. Control groups were treated identically but were not
UV irradiated. The data from two separate experiments were
combined and are presented in Table I. Tamarind XG and OGA
appeared to reduce slightly the response to C. albicans in non-UV-
irradiated mice; however, this effect was not consistent between
experiments. In the absence of the polysaccharide/oligosaccharide
treatment, UV irradiation severely reduced the DTH responses of
the animals to both C. albicans and alloantigen compared with their
matched, unirradiated controls. Polysaccharide/oligosaccharide
treatment provided partial to complete protection of DTH
immunity. Thus, the polysaccharides/oligosaccharides protect
systemic DTH immune responses from the suppressive effects of
UV radiation administered as either a single exposure to a high dose
(30 kJ per m2) or as multiple smaller doses (Strickland et al, 1999).
Protection of CHS responses We investigated the speci®city
of immune protection by the polysaccharides/oligosaccharides by
testing the effectiveness of the compounds in protecting local and
systemic CHS responses to hapten. For suppression of local
immunity, the shaved ventral skin of C3H/HeN mice was
exposed to 2 kJ per m2 UVB radiation and treated with tamarind
XG/PBS, OGA/PBS, or PBS alone. The UV-irradiated and
unirradiated controls were sensitized with the hapten, DNFB 3 d
later. Exposure to UV radiation reduced the response of mice to
DNFB by greater than 50% compared with their nonirradiated,
matching controls (Table II). Neither tamarind XG nor OGA
restored immunity to the hapten even though the dose of UV
radiation used in these experiments was far less than those used to
suppress DTH immunity, as shown in Table I. Tamarind and
OGA polysaccharides/oligosaccharides also failed to prevent
systemic suppression of CHS responses to DNFB when the mice
were given a higher (15 kJ per m2) UV radiation and sensitized
through unirradiated skin (not shown). Taken together, the results
show that tamarind XG and OGA polysaccharides/oligosaccharides
activity is speci®c for the pathways involved in the UV-induced
suppression of systemic DTH immune responses but does not
protect CHS immunity to hapten.
Effect of polysaccharides/oligosaccharides on DTH
immunity and suppressor T cells induction during chronic
UV irradiation As amounts of UV radiation necessary to
suppress tumor immunity are greater than those required to
suppress T cell responses to model antigens, we determined the
ability of the polysaccharides/oligosaccharides to protect DTH
responses from the effects of a subcarcinogenic treatment with UV
radiation (Kripke, 1974; De Fabo and Kripke, 1979; Sontag et al,
Table I. Protection by polysaccharides/oligosaccharides of DTH immune responses to C. albicans in mice after repeated
exposure to UV irradiation for 1 wk
Treatment Antigen Mean 6 SEM
footpad swellinga (mm)
Per cent speci®c suppressionb p
None Nonec 43 6 4
None C. albicansd 195 6 11 ±
Tamarinde C. albicans 167 6 10 ±
OGAe C. albicans 185 6 4 ±
UVf C. albicans 65 6 7 86 (p < 0.001)g
UV/tamarindh C. albicans 138 6 10 23 (p = NS)g
UV/OGA C. albicans 116 6 8 49 (p < 0.001)
None Nonec 64 6 7i
None Alloantigenj 191 6 6 ±
Tamarind Alloantigen 913 6 8 ±
OGA Alloantigen 177 6 4 ±
UV Alloantigen 97 6 5 66 (p < 0.001)
UV/tamarind Alloantigen 157 6 6 28 (p = 0.01)
UV/OGA Alloantigen 145 6 4 28 (p < 0.001)
aData are from two experiments combined. Each group in a single experiment contained ®ve C3H/HeN mice each. The data are expressed as the mean 6 SEM from
10 C3H/HeN mice.
bVersus unirradiated, homologous control.
cChallenged but not sensitized.
dSensitized subcutaneous with 2 3 107 formalin-®xed C. albicans cells per mouse.
eEach mouse was treated with 1 ml of a solution of 1 m per ml tamarind XG or OGA in PBS three times per week. The mice were sensitized with antigen 2 h after the
last treatment.
fMice were exposed on their shaved dorsal skin to 15 kJ per m2 UVB from FS40 sunlamps three times per week and sensitized 2 h after the last treatment.
gDetermined by ANOVA. NS, p > 0.05.
hUV-irradiated skin was treated with tamarind or OGA immediately after each UV exposure. The mice were sensitized 2 h after the last treatment.
iMice were challenged in each hind footpad with 1 3 107 BALB/C spleen cells.
jEach mouse was sensitized subcutaneously with 5 3 107 BALB/C spleen cells.
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1997). Using the chronic UV irradiation model described by
De Fabo and Kripke (1979), the mice were UV irradiated 33 per
week for 12 wk. After each UV exposure, the animals and their
unirradiated control groups were treated with tamarind XG or
OGA. Groups of UV-irradiated and nonirradiated control animals
were removed from the experiment after 6 and 12 wk of treatment
(cumulative dose of UVB: 270 kJ per m2 and 540 kJ per m2,
respectively) to assess their DTH response to C. albicans and
alloantigen. Chronic UV irradiation reduced the DTH responses of
the animals to C. albicans (Table III) and alloantigen (Table IV) to
near background levels compared with unirradiated matching
control groups. Tamarind XG and OGA treatment provided partial
protection of DTH immunity to C. albicans from 6 wk of chronic
UV irradiation but protection was lost by 12 wk of treatment (left
half of Table III). Unlike the DTH response to C. albicans,
however, both tamarind XG and OGA were highly effective at
preventing suppression of DTH responses to alloantigen even after
12 wk of UV irradiation (left half of Table IV).
Suppressor T lymphocytes found in the spleen of chronically
UV-irradiated mice, contribute to the growth of highly antigenic
skin tumors by preventing their antigen-speci®c immune rejection
(Fisher and Kripke, 1974). We therefore assessed the presence of
suppressor cells in the UV-irradiated animals after 6 and 12 wk of
treatment by transferring the spleen cells from the UV-irradiated,
untreated or polysaccharide-treated animals to syngenic, unim-
munized recipients. Spleen cells from untreated donor mice given 6
and 12 wk of UV radiation inhibited the induction of DTH
response to C. albicans (right half Table III) and alloantigen (right
half Table IV) in the syngeneic recipient animals. OGA blocked
suppressor cell formation to Candida antigen in mice treated for up
to 6 wk with UV radiation; however, by 12 wk of UV treatment
the immunoprotective activity of the OGA was overcome
(Table III). Tamarind XG was less effective than OGA at
preventing the generation of suppressor cells and its protective
activity was overcome by 6 wk of UV treatment (cumulative dose
270 kJ per m2 ). Unlike immune responses to C. albicans, both
tamarind XG and OGA were equally effective in preventing the
formation of splenic suppressor cells to alloantigen even in animals
Table III. Effects of tamarind XG and OGA on suppression of DTH immunity to C. albicans and the generation of splenic Ts
cells in mice exposed to chronic UV irradiation
DTH response in spleen cell donors DTH response in spleen cell recipients
Mean 6 SEM Mean 6 SEM
Weeks of Treatment of footpad % Speci®c Treatment of footpad % Speci®c
treatment spleen cell donors swelling (mm)a suppressionb spleen cell recipients swelling (mm) suppressionc
6 Noned 32 6 5 No cells, no C. albicans 37 6 8 ±
C. albicanse 164 6 13 ± No cells, C. albicans 279 6 33 ±
Tamarind/C. albicanse,f 140 6 16 ±
OGA/C. albicanse,f 145 6 6 ±
UV/C. albicanse,g 58 6 6 80 (p < 0.001)h Spleen cells from UV/C. albicansi 166 6 12 47 (p = 0.01)
UV/tamarind/C. albicansj 90 6 7 41 (p = 0.01) Spleen cells from UV/tamarind/C. albicans 184 6 11 39 (p = 0.03)
UV/OGA/C. albicans 116 6 8 26 (p = 0.02) Spleen cells from UV/OGA/C. albicans 221 6 22 24 (p = NS)
12 None 50 6 5 No cells, no C. albicans 37 6 4
C. albicans 190 6 8 ± No cells, C. albicans 169 6 7
Tamarind/C. albicans 148 6 6 ± NR spleen/C. albicansk 182 6 11
OGA./C. albicans 142 6 8
UV/C. albicans 65 6 10 89 (p < 0.001) Spleen cells from UV/C. albicans 106 6 4 48 (p < 0.001)
UV/tamarind/C. albicans 30 6 8 100 (p < 0.001) Spleen cells from UV/tamarind/C. albicans 95 6 6 56 (p < 0.001)
UV/OGA/C. albicans 86 6 6 64 (p < 0.001) Spleen cells from UV/OGA/C. albicans 99 6 7 53 (p < 0.001)
aData are from two experiments combined. Each group in a single experiment contained ®ve C3H/HeN mice. The data are expressed as the mean 6 SEM of 10 mice.
bVersus unirradiated, homologous control.
cVersus unirradiated, sensitized control.
dChallenged with soluble C. albicans antigen but not sensitized.
eSensitized subcutaneously with 2 3 107 formalin-®xed C. albicans per mouse.
fEach mouse was treated 33 per week with 1 ml of a solution of 1 mg per ml tamarind XG or OGA in PBS. The mice were sensitized with antigen after the last
treatment.
gMice were exposed to 15 kJ per m2 UVB 33 per week and sensitized with formalin-®xed C. albicans 2 h after the last treatment.
hDetermined by ANOVA. p > 0.05 = NS (not signi®cant.
iSpleen cells from donors in the left half of the table were transferred intravenously to unimmunized, syngeneic recipients. The spleen cell recipients were then sensitized
with formalin-®xed C. albicans cells.
jUV-irradiated skin was treated with 1 mg per ml tamarind XG or OGA in PBS immediately after each UV exposure. The mice were sensitized with formalin-®xed
C. albicans 2 h after the last treatment.
kNR, spleen cells from unimmunized, syngeneic animals.
Table II. Failure of tamarind seed XG and pectinic OGA to
prevent suppression of the CHS exposure to DNFB in mice
exposed to a single dose of UV radiation
Mean 6 SEM
ear swelling % Speci®c
Treatment (mm)a suppressionb pc
Noned 23 6 3
DNFBe 125 6 4 ±
Tamarind/DNFBf 96 6 4 ±
OGA/DNFBf 104 6 5 ±
2 kJ per m2 UV/DNFBg 64 6 4 60 (p = 0.03)g
2 kJ per m2 UV/tamarind/DNFBh 65 6 7 43 (p = 0.04)f
2 kJ per m2 U/OGA/DNFB 76 6 5 35 (p = 0.02)
aData represent the mean 6 SEM from groups of ®ve female C3H/HeN mice.
The data are from representative of three experiments.
bVersus unirradiated, homologous control.
cStudents t test.
dChallenged but not sensitized.
eSensitized with 0.3% DNFB in acetone. The mice were challenged 6 d later
with 0.2% DNFB in acetone.
fEach mouse was treated with 1 ml of a solution of 1 mg per ml tamarind XG or
OGA in PBS. The mice were sensitized with 0.3% DNFB in acetone 3 d later and
challenged 6 d after sensitization.
gMice were exposed to 2 kJ per m2 UVB from FS40 sunlamps on their shaved
abdominal skin. The mice were sensitized with 0.3% DNFB in acetone 3 d later
and challenged 6 d after sensitization.
hUV-irradiated skin was treated with tamarind XG or OGA immediately after
exposure. The mice were sensitized with 0.3% DNFB 3 d later and challenged 6 d
after sensitization.
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treated with UV radiation for 12 wk (right half Table IV). Taken
together, these results show that DTH responses are complex and
that conditions that favor the generation of suppressor cells speci®c
for one antigen may not result in the generation of suppressor cells
to a different antigen. They further suggest that all surrogate
markers for tumor immunity are not alike. Therefore, we directly
examined the relationship between DTH responses to the model
antigens and tumor immunity.
Effect of tamarind XG and OGA on tumor immunity Mice
remaining in the experiments after the 12 wk of treatment
described above but that were not immunized, were injected
subcutaneously with cells from a highly antigenic, syngenic
regressor tumor. This cell line, UV5497-5, was recently derived
from a ®brosarcoma arising in the skin of a C3H/HeN mouse
during chronic treatment with UV radiation. A normal (untreated)
age-matched group of mice was exposed to a sublethal dose of X-
irradiation and injected with the tumor cells as a positive control for
tumor growth. The data presented in Fig 1 are from one of two
experiments and show that the tumor cells grew rapidly in all the
mice whose immune system was suppressed by the X-irradiation.
Only 10±20% of unirradiated, non-UV-exposed mice developed
tumors. The tumor cells injected into these mice produced palpable
tumors that were too small to measure accurately and were
completely rejected 4 wk after transplantation. Neither tamarind
XG nor OGA affected tumor incidence or growth in non-UV-
irradiated mice. In contrast, tumors progressively developed in all
UV-irradiated, untreated or polysaccharide/oligosaccharide-treated
mice. Once these tumors appeared, they progressively grew in size
until the animals were moribund and had to be killed (not shown).
Neither the tamarind XG or OGA polysaccharides/oligo-
saccharides signi®cantly affected the appearance of tumors or
their rate of growth compared with the untreated, UV-irradiated
group (not shown). Thus, protection of immune responses to
alloantigen from suppression by chronic UV irradiation was
unrelated to the ability of the animal to reject a transplanted,
highly immunogenic, UV-induced skin tumor.
Table IV. Effects of tamarind XG and OGA on suppression of DTH immunity to alloantigen and the generation of splenic Ts
cells in mice exposed to chronic UV irradiation
DTH response in spleen cell donors DTH response in spleen cell recipients
Mean 6 SEM Mean 6 SEM
Weeks of Treatment of footpad % Speci®c Treatment of footpad % Speci®c
treatment spleen cell donors swelling (mm)a suppressionb spleen cell recipients swelling (mm) suppressionc
6 Noned 42 6 5 No cells/no alloantigen 51 6 3 ±
Alloantigene 165 6 11 ± No cells/alloantigen 212 6 15 ±
Tamarinde,f 193 6 15 ± NR, spleen cells/alloantigeng 191 6 9
OGAe,f 171 6 6
UV/alloantigen e,h 66 6 7 80 (p < 0.001)i Spleen cells from UV/alloantigenj 99 6 8 70 (p < 0.001)
UV/tamarind/alloantigenk 114 6 12 53 (p = 0.002) Spleen cells from UV/tamarind/alloantigen 155 6 11 35 (p = 0.01)
UV/OGA 114 6 6 44 (p < 0.001) Spleen cells from UV/OGA/alloantigen 151 6 24 38 (p = NS)
12 None 42 6 8 No cells, no alloantigen 52 6 8
Alloantigen 196 6 7 ± No cells/alloantigen 200 6 10
OGA 172 6 6 NR spleen cells/alloantigen 195 6 7
Tamarind 170 6 15 ±
UV 54 6 7 92 (p < 0.001) UV 110 6 6 61 (p < 0.001)
UV/tamarind 157 6 15 10 (p = NS) UV/tamarind 226 6 6 0 (NS)
UV/OGA 150 6 10 16 (p = NS) UV/OGA 205 6 13 0 (NS)
aData are from two experiments combined. Each group in a single experiment contained ®ve C3H/HeN mice. The data are expressed as the mean 6 SEM of 10 mice.
bVersus unirradiated, homologous control.
cVersus unirradiated, sensitized control.
dChallenged in the hind footpads with 1 3 107 BALB/C spleen cells per mouse but not sensitized.
eSensitized subcutaneously with 5 3 107 BALB/C spleen cells (alloantigen) per mouse.
fEach mouse was treated 33 per week with 1 ml of a solution of 1 mg per ml tamarind XG or OGA in PBS. The mice were sensitized with antigen after the last
treatment.
gNR, spleen cells from unimmunized, syngeneic animals.
hMice were exposed to 15 kJ per m2 UVB 33 per week and sensitized with BALB/C spleen cells 2 h after the last treatment.
iDetermined by ANOVA. p > 0.05 = NS (not signi®cant).
j1 3 108 nucleated spleen cells per mouse from donors in the left half of the table were transferred intravenously to unimmunized, syngeneic recipients. The spleen cell
recipients were then sensitized with alloantigen.
kUV-irradiated skin was treated with 1 mg per ml tamarind XG or OGA in PBS immediately after each UV exposure. The mice were sensitized with alloantigen 2 h after
the last treatment.
Figure 1. Effect of tamarind XG polysaccharide and OGA
oligosaccharide on the growth of a transplanted UV-induced
tumor. Groups of 10 C3H/HeN mice were exposed to 15 kJ per m2
UVB radiation followed by treatment of the irradiated skin with 1 mg
tamarind XG/PBS, OGA/PBS, or PBS alone. The UV-irradiated and
nonirradiated control groups were treated 33 per week for 12 wk followed
by transplantation subcutaneously of 5 3 105 UV5497-5 tumor cells. One
group of untreated, normal C3H mice was X-irradiated (450 R) 24 h
before receiving the tumor cells. The results shown are from one of two
separate experiments.
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DISCUSSION
Application of tamarind XG and OGA polysaccharides/oligosac-
charides to the UV-irradiated skin of mice protects DTH responses
to both C. albicans and alloantigen from suppression by a single
exposure of UVB radiation (Strickland et al, 1999). Our study
extends those investigations to assess the ability of the compounds
to prevent suppression from repeated acute UV exposure over a
short period and from chronic UV exposure at levels suf®cient to
suppress tumor immunity. The results show that the therapeutic
saccharides progressively lose their ability to protect DTH immune
responses to C. albicans, but not alloantigen during the course of
chronic UV irradiation. Thus, there are signi®cant differences in
the regulation of DTH immune responses to the two antigens
during chronic UV treatment that are not re¯ected in acute models
of UV-induced immune suppression.
One explanation for these differences may be that the relation-
ship between the tissue damage caused by UV radiation and the
host response to the injury is dynamic and changes with time. In
our study, this interaction could account for the progressive loss of
protection of DTH responses to C. albicans and the appearance of
suppressor cells in the spleens of the UV-irradiated, polysaccharide/
oligosaccharide-treated animals over time. Biologic adaptation has
been shown to occur during chronic exposure to UV radiation and
may in¯uence the ®nal outcome of treatment. During early phases
of chronic UV irradiation, Ia+ and DETC cells are depleted from
the epidermis followed by an increase in Ia+ but not DETC cells
(Alcalay et al, 1989). Antigen-presenting cell functions are also
impaired during chronic UV irradiation, but recover when tumor
development occurs (Alcalay and Kripke, 1991). Biologic adapta-
tion to chronic UV irradiation also occurs in the effector phase of
the immune response. For example, recall responses in humans to
puri®ed protein derived antigens measured by the Mantoux skin
test, were signi®cantly more suppressed by acute UV irradiation
than by prolonged UV exposure, indicating that adaptive
mechanisms may have counteracted some of the immunosuppres-
sive effects of UV radiation (Damian et al, 1998). Changes in
regulation of immune responses over time are not restricted to the
biologic consequences of exposure to UV radiation. Repeated
administration of antigen or the chemical properties of an antigen
both in¯uence T cell and B cell responses, resulting in changing
immunoglobulin gene rearrangements and expression of B cell
subpopulations over time (Strickland et al, 1989). Thus, regulation
of immune responses is complex, changes with time, and is antigen
dependent.
The mechanism of regulation of immune responses to different
antigens by acute or chronic UV irradiation are poorly understood.
Work from several laboratories demonstrate that acute exposure to
UV radiation suppresses CHS and DTH responses by different
mechanisms (Kripke and Morison, 1986; Daynes et al, 1986;
Beissert and Granstein, 1995; Moodycliff et al, 1996; Kim et al,
1998). Suppression of CHS responses by UV radiation is triggered
by DNA damage-mediated pathways and involves alterations in
Langerhans cell functions, the release of tumor necrosis factor-a,
interleukin (IL)-1 cytokines, and prostaglandin E2 (Chung et al,
1986; Robertson et al, 1987; Harriott-Smith and Haliday, 1988;
Vermeer and Streilein, 1990; Simon et al, 1991). Enzymatic repair
of UV-induced cyclopyrimidine dimers restores the immune
response to haptens and the DTH response to C. albicans (Kripke
et al, 1992; Vink et al, 1996). In contrast, antibodies speci®c for cis-
urocanic acid (cis-UCA) and IL-10 block UV-induced systemic
suppression of DTH responses to alloantigen and herpes simplex
virus but not local CHS responses to haptens (Noonan and De
Fabo, 1992; Ullrich, 1994; Moodycliff et al, 1996). Cis-UCA has
been found systemically to suppress CHS responses to haptens
through its action on mast cells (Hart et al, 1999). The roles of
regulatory pathways triggered by DNA damage or cis-UCA in the
suppression of immunity by chronic UV irradiation are currently
unknown.
Tamarind XG and OGA are probably not exerting their
protective effects directly by stimulating the repair of UV-induced
DNA damage as the immune-protective polysaccharides/oligosac-
charides from aloe do not stimulate repair of cybutylpyrimidine
dimers in UV-irradiated murine skin (Strickland et al, 1994).
Polysaccharides/oligosaccharides from tamarind XG, OGA, and
aloe, however, can preserve DTH immunity by preventing the
production of immunosuppressive cytokines such as IL-10 by UV-
irradiated keratinocytes in vivo and in vitro (Strickland et al, 1999).
Although in our model the polysaccharides/oligosaccharides do not
block the isomerization of trans- to cis-UCA because they were
applied to the skin after UV irradiation, they may in¯uence the
regulation of pathways triggered by cis-UCA. Further studies are
needed to determine the action of the polysaccharides/oligosac-
charides on these pathways during chronic UV irradiation.
This study was undertaken in part to clarify the role of DTH to
contact allergens (CHS) and DTH immune responses to proteins in
rejection of UV-induced nonmelanoma skin cancer. Both CHS
and DTH responses are delayed-in-time and are T cell-mediated,
although CHS immune responses are generally thought to be a
subset of DTH immunity. Donawho et al (1992) showed that
suppression of DTH responses to protein antigens but not CHS to
hapten was important in UV enhanced outgrowth of melanoma.
Similarly, Steerenberg et al (1997) were unable to correlate
protection of CHS immune responses to picryl chloride and UV
carcinogenesis, suggesting a dissociation between CHS and tumor
immunity; however, the conditions used by these authors would
also suppress DTH immunity to protein antigens. The ability of
quercetin to protect DTH responses from suppression by UV
radiation has not, to our knowledge, been reported. The selective
protection of DTH immunity in the absence of protection of CHS
responses in our model provides the unique opportunity for
elucidating the role of DTH in the rejection of nonmelanoma skin
cancer. Our ®ndings that DTH immunity to alloantigen did not
correlate with tumor rejection have several interpretations. First, T
cell-mediated immune responses are complex and antigen
dependent. The correlation between the loss of DTH to
C. albicans and failure to reject a highly antigenic tumor may re¯ect
the nature of the antigens, their processing, the subpopulations of
antigen-presenting cells, and suppressor T cells involved. Quercetin
preserves the function of Langerhans cells in the skin but may not
affect antigen-presenting cells in the spleen (Steerenberg et al,
1997). DTH immunity to alloantigen and C. albicans involves
differences in both antigen processing and presentation. Second,
CHS responses to DNFB and DTH to C. albicans are mechanisms
required for tumor rejection. This interpretation agrees with the
®ndings of Yoshikawa et al (1990), who correlated tumor
susceptibility in humans with sensitivity to the suppressive effects
of UV radiation on CHS responses. A negative association (lack of
responsiveness to the model antigen and failure to reject a
transplanted tumor), however, does not conclusively demonstrate
a causal relationship between these immune pathways and a
mechanism for tumor rejection. Finally, the recognition and
rejection of nonmelanoma skin tumors may require both CHS and
DTH immune pathways to be intact. This hypothesis can be tested
using a combination of agents that selectively protect CHS and
DTH immune responses.
The relationship between suppressor cells speci®c for the model
antigens or for tumor is at present unknown. Also unknown is the
nature of the antigen shared by UV-induced tumors and recognized
by effector and suppressor T cells. In this study, suppressor cells
speci®c for C. albicans antigen appeared in the polysaccharide/
oligosaccharide-treated groups after approximately 6 wk of irradia-
tion and increased by 12 wk of UV irradiation whereas the
polysaccharides/oligosaccharides completely blocked the genera-
tion of these cells to alloantigen. Despite the absence of suppression
of DTH immunity to antigen, the mice were unable to reject a
highly antigenic transplanted skin tumor. These results suggest that
suppressor cells are heterogeneous and that under the same
conditions, they may be present to one antigen and absent for
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another. Evidence for the heterogeneity of UV-induced suppressor
T cell populations was provided by our laboratory (Shreedhar et al,
1998) and by Moodycliffe et al (1999). The results from those
studies showed that cloned, UV-induced, hapten-speci®c suppres-
sor T lymphocytes belonged to the Tr-1 family of regulatory T cells
whereas CD4+ NK-1.1+ T cells suppress DTH immune responses
to proteins and tumor antigens. The results of the current study
indicate that DTH immunity is more complex than was previously
thought and the mechanisms of UV-induced suppression to
different antigens must be further clari®ed.
In summary, our results demonstrate that there can be signi®cant
differences between the effects of acute and chronic UV radiation
on immune responses to model antigens. Furthermore, caution
must be used when extrapolating the results from surrogate tests for
tumor immunity to actual capacity to reject tumors as DTH
immune responses are more complex than were previously
thought. More work is necessary to clarify mechanisms involved
in the suppression of immune responses to model antigens by
chronic UV radiation, the mechanisms of antigen-speci®c
suppressor cell induction, and their relation to tumor immunity.
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